Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome.
作者:
主题词
老年人(Aged);抗淋巴细胞血清(Antilymphocyte Serum);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);综合疗法(Combined Modality Therapy);无病生存(Disease-Free Survival);可行性研究(Feasibility Studies);女(雌)性(Female);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类嗜T淋巴细胞病毒1型(Human T-lymphotropic virus 1);人类(Humans);免疫抑制剂(Immunosuppressive Agents);Kaplan-Meiers评估(Kaplan-Meier Estimate);白血病淋巴瘤, 成人T细胞(Leukemia-Lymphoma, Adult T-Cell);男(雄)性(Male);中年人(Middle Aged);比例危险度模型(Proportional Hazards Models);原病毒(Proviruses);存活率分析(Survival Analysis);T淋巴细胞(T-Lymphocytes);移植预处理(Transplantation Conditioning);移植, 同种(Transplantation, Homologous);治疗结果(Treatment Outcome)
DOI
10.1016/j.bbmt.2008.03.010
PMID
18489996
发布时间
2010-11-18
- 浏览16
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文